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Background: After experiencing a stroke, most individuals also suffer from cardiac disease, are immobile and thus
have low endurance for exercise. Aerobic capacity is seriously reduced in these individuals and does not reach
reasonable levels after conventional rehabilitation programmes. Cardiovascular exercise is beneficial for
improvement of aerobic capacity in mild to moderate stroke. However, less is known about its impact on aerobic
capacity, motor recovery, and quality-of-life in severely impaired individuals. The aim of this pilot study is to explore
the clinical efficacy and feasibility of cardiovascular exercise with regard to aerobic capacity, motor recovery, and
quality-of-life using feedback-controlled robotics-assisted treadmill exercise in non-ambulatory individuals soon after
experiencing a stroke.
Methods/Design: This will be a single-centred single blind, randomised control trial with a pre-post intervention
design. Subjects will be recruited early after their first stroke (≤20 weeks) at a neurological rehabilitation clinic and
will be randomly allocated to an inpatient cardiovascular exercise programme that uses feedback-controlled
robotics-assisted treadmill exercise (experimental) or to conventional robotics-assisted treadmill exercise (control).
Intervention duration depends on the duration of each subject’s inpatient rehabilitation period. Aerobic capacity,
as the primary outcome measure, will be assessed using feedback-controlled robotics-assisted treadmill-based
cardiopulmonary exercise testing. Secondary outcome measures will include gait speed, walking endurance,
standing function, and quality-of-life. Outcome assessment will be conducted at baseline, after each 4-week
intervention period, and before clinical discharge. Ethical approval has been obtained.
Discussion: Whether cardiovascular exercise in non-ambulatory individuals early after stroke has an impact on
aerobic capacity, motor recovery, and quality-of-life is not yet known. Feedback-controlled robotics-assisted
treadmill exercise is a relatively recent intervention method and might be used to train and evaluate aerobic
capacity in this population. The present pilot trial is expected to provide new insights into the implementation of
early cardiovascular exercise for individuals with severe motor impairment. The findings of this study may guide
future research to explore the effects of early cardiovascular activation after severe neurological events.
Trial registration: This trial is registered with the Clinical Trials.gov Registry (NCT01679600).
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Cardiovascular-related diseases are the leading causes of
death [1] and long-term disability worldwide [2]. Stroke
affects about 15 million people each year, whereby 5 mil-
lion die and another 5 million remain permanently dis-
abled [3]. It has been estimated that stroke will occur in
35% of the population over the age of 65, a group that
will increase in proportion due to demographic shifts in
most populations [4]. This leads to an increased need
for effective rehabilitation programmes to enhance re-
covery, improve functional status and quality-of-life,
while considering the future challenges in worldwide
health care economics [5].
To date, stroke rehabilitation research has focussed
primarily on restoring motor control to promote inde-
pendent function during daily life. However, around 75%
of post-stroke individuals suffer from cardiac disease
[6,7], and the majority have low endurance for exercise
as a consequence of immobility [8]. Previous work has
shown that peak oxygen uptake (VO2peak) is reduced to
10 to 17 mL/min/kg within the first 30 days after stroke
[9-11] and does not rise over 20 mL/min/kg after 6
months [11-14]. These values are 25 to 45% lower than
VO2peak in age-matched healthy subjects [15,16]. This
early and persistent decline in aerobic capacity can
delay or inhibit participation in a therapeutic exercise
programme, cause difficulties in the rehabilitation
process and long-term post-stroke course of care, and
limits an individual’s independent performance of func-
tional activities [7,17].
In a recent meta-analysis it has been shown that car-
diovascular exercise is beneficial for improving VO2peak
and walking endurance in mild to moderately impaired
individuals in sub-acute stroke (1 week to 6 months after
onset) [18]. However, less is known about its impact on
motor recovery, quality-of-life, and mortality. Previous
trials did not consider post-stroke individuals with se-
vere motor impairments due to the challenge of
selecting appropriate training modalities and evaluation
of effectiveness (for example, aerobic capacity). About
50% of stroke survivors may be non-ambulatory or even
unable to walk a speed or distance necessary to achieve
aerobic benefits [19]. This leads to inadequate training
programmes and restricts the performance of valid car-
diopulmonary exercise testing protocols. Given the fact
that most motor recovery occurs in the first 3 months
after a stroke [20], sub-acute rehabilitation programmes
have to target neuromuscular recovery as well as cardio-
vascular exercise to optimize intervention outcomes.
This could be achieved by the implementation of assis-
tive devices to promote functional activities such as
walking or stair climbing.
The application of robotics-assisted walking thus has
substantial clinical potential. The technology offers severaladvantages over conventional rehabilitation strategies,
such as motor function related training programmes
within controlled evaluation settings, even for indi-
viduals with severe motor impairments. Robotics-assisted
treadmill exercise (RATE), consisting of driven gait or-
thoses with an integrated body weight unloading system,
opens new perspectives for cardiovascular exercise and
evaluation of aerobic capacity in the early stages after
stroke.
A novel assessment protocol has been developed to es-
timate key cardiopulmonary performance parameters
during RATE [21,22]. This incorporates a human-in-the-
loop feedback mechanism, which allows individuals to
maximise their voluntary input and associated cardiovas-
cular stress. A previous study provided evidence for the
concept of feedback-controlled RATE (FC-RATE) to
evaluate aerobic capacity and guide cardiovascular exer-
cise in non-ambulatory individuals with sub-acute stroke
[23]. Cardiopulmonary performance parameters yielded
reasonable values following standardised exercise testing
protocols. The next logical step is to evaluate the clinical
efficacy and feasibility of the concept during early stroke
rehabilitation. It has been hypothesised that FC-RATE is
feasible and effective for maintenance or improvement
of aerobic capacity in non-ambulatory individuals with
sub-acute stroke. This might be highly relevant for fur-
ther research to explore the association between cardio-
vascular rehabilitation and neural plasticity during early
stroke rehabilitation.
This randomised controlled pilot trial aims: (1) to ex-
plore the clinical efficacy of early cardiovascular exercise
on aerobic capacity, motor recovery, and quality-of-life;
(2) to evaluate the feasibility of FC-RATE for cardiovas-
cular rehabilitation in non-ambulatory individuals after
stroke; and (3) to put forward recommendations for
development and design of larger clinical trials regar-
ding cardiovascular rehabilitation early after stroke.Methods/Design
All procedures involved in this trial will be conducted in
compliance with national ethical standards and the
Helsinki Declaration. Ethical approval has been obtained
from the ethics committee of the canton of Aargau in
Switzerland (Reference No. 2012/051).Design and setting
This study is a single-centred single blind, randomised
control trial with a pre-post intervention design. Sub-
jects will be recruited at a neurological rehabilitation
clinic in the northwestern part of Switzerland (Reha
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Figure 1 Flow chart outlining the study protocol. A 4-week intervention period includes baseline assessments (t0) and first post-intervention
(t1) assessments (solid line). The dashed line represents a potential continuation of the intervention due to extended inpatient rehabilitation.
Post-intervention assessments will be conducted after every 4-week intervention period and before clinical discharge.
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Subjects will be enrolled after their first stroke if they
are non-ambulatory. Inclusion criteria are: (1) clinical
diagnosis of an initial stroke, (2) ≤20 weeks post-stroke
at intervention onset, (3) age ≥18 years, (4) Functional
Ambulation Category (FAC) ≤3, and (5) ability to under-
stand the procedures and provide informed consent.
Exclusion criteria are: (1) contraindications for cardio-
pulmonary exercise testing as outlined by the American
College of Sports Medicine (ACSM) [24], (2) contraindi-
cations for RATE according to the device manufacturer,
(3) concurrent neurological disease, (4) concurrent pul-
monary disease, and (4) history of dementia.Recruitment
Potential subjects will be screened daily by searching the
admission lists of the rehabilitation centre. The projectleader will approach eligible subjects and explain the
purpose of the study and ask whether potentially qualify-
ing individuals have an interest in participating. If a po-
tential subject expresses interest, the study will be
explained in detail, all questions will be addressed and
the subject will be invited to participate by providing
signed informed consent. Subjects then will be referred
for specific cardiac examination by a cardiologist to de-
tect potential contraindications for cardiopulmonary ex-
ercise testing. The project leader and the responsible
physician will make a final decision on inclusion.Randomisation, allocation concealment, and blinding
Subjects will be randomly allocated to an experimental
group (FC-RATE) or to a control group (RATE). An in-
dependent researcher will generate a 4-block randomisa-
tion list and send it to the clinic's pharmacy for
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call the pharmacy to request a subject’s allocation. Only
the treating therapists will have access to the allocated
documents. The project leader, who is blind for alloca-
tion of the subjects, will carry out all testing procedures
as an independent examiner. A further research assistant
will be responsible for data input. Subjects will be told
not to talk to the examiner about the group allocation
or therapy content during the post-intervention assess-
ments. Randomisation will be concealed to the inde-
pendent examiner until the last post-intervention
assessment has been performed. The data will be




Peak oxygen uptake (VO2peak) Peak oxygen uptake in the last 30 s
Peak work rate (Ppeak) Maximal work rate during IET
Peak heart rate (HRpeak) Maximal heart rate during IET
Peak ventilation rate (VEpeak) Peak ventilation rate in the last 30 s
Peak respiratory rate (Rfpeak) Peak respiratory rate in the last 30 s
Peak respiratory exchange ratio
(RERpeak)
Value of the oxygen uptake and carb
Gas exchange threshold (GET) Oxygen uptake at the point at which
in proportion to oxygen uptake duri
standard gas exchange criteria
Oxygen cost of work (ΔVO2/ΔP) Δ oxygen uptake/Δ work rate
Heart rate response (ΔHR/ΔVO2) Δ heat rate/Δ oxygen uptake
Peak oxygen pulse (VO2peak/HRpeak) Peak oxygen uptake/peak heart rate
Time constants of oxygen uptake
during on-/off-transition (τ)
Time taken for oxygen uptake to rea
is modelled as a mono-exponential
Steady-state increase in oxygen
uptake (ΔVO2)
Steady-state increase in oxygen upta
intensity during CLT
Steady-state increase in heart rate
(ΔHR)
Steady-state increase in heart rate fo
during CLT
Steady-state increase in ventilation
rate (ΔVE)
Steady-state increase in minute rate
during CLT
Steady-state increase in respiratory
rate (ΔRf)
Steady-state increase in respiratory r
intensity during CLT
Oxygen cost of work during constant
load (VO2/P)
Oxygen uptake versus work rate dur
Secondary outcomes
RMS deviation of work rate RMSEP Work rate tracking error during feed
Gait speed 10 Meter Walk Test (10MWT)
Walking endurance 6 Minute Walk Test (6MWT)
Standing function Standardised protocol to assess stan
Quality-of-life Stroke Impact Scale (SIS)
Feasibility Criteria for success
CLT, Constant load testing; IET, incremental exercise testing; RMSE, root mean squaOutcome measures
All primary and secondary outcome measurements will
be carried out at baseline (t0), after each 4-week inter-
vention period (t1, t2, t3, etcetera), and before clinical
discharge. At baseline, descriptive variables for each sub-
ject include age, sex, area and type of infarct, side of
stroke, time since stroke onset, body height and body
mass.
A summary of the primary and secondary outcome
measures can be found in Table 1. The primary outcome
will be aerobic capacity, the accepted criterion for
exercise capacity [24]. We will estimate standardised
cardiopulmonary performance parameters based onUnit
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sures will focus on physical performance, stroke impact,
and feasibility. We will evaluate the work rate tracking
error during FC-RATE by calculating the root mean
square error (RMSE) between actual work rate and tar-
get work rate values. Gait speed will be assessed using
the 10 Meter Walk Test (10MWT) [26,27]. Walking en-
durance will be measured using the 6 Minute Walk Test
(6MWT), the distance that an individual is able to walk
in 6 minutes on a hard, flat surface [28,29]. To assess
basic standing function in non-ambulatory subjects, we
will employ a standardised standing test on a force plate.
The subject will be requested to: (1) stand in bipedal
stance, (2) shift his/her body weight from the right to
the left leg alternately, and (3) shift his/her body weight
in a defined rhythm from the right to the left leg alter-
nately. The test-retest reliability of centre of pressure
measures in bipedal tasks has been shown previously
[30]. We will use the Stroke Impact Scale (SIS) to assess
recovery and quality-of-life after stroke [31].
The feasibility of the study protocol will be based on
defined criteria for success such as compliance, attrition,
safety, and successful data processing. We define feasibil-
ity to be affirmed with compliance to the study protocol
of ≥90%, an attrition rate of ≤10%, clinical safety of 100%,
and effective data processing of 100%. The overall feasi-
bility of the study will be rated using the following out-
comes: (i) protocol deemed feasible (when all criteria for
success can be achieved), (ii) protocol deemed feasible
with minor modifications (≥75% of the criteria for suc-
cess can be achieved), (iii) protocol deemed feasible with
major modifications (≥50% of the criteria for success can
be achieved), and (iv) protocol deemed not feasible (none























Figure 2 Feedback-controlled robotics-assisted treadmill exercise. The
the subject. The dashed line represents the target work rate (P*mech). The p
and subtracted from Pmech. Legend: Praw = raw mechanical work rate, Μi =
work rate.Instrumentation
We will use the Lokomat driven-gait orthosis system
(Hocoma AG, Volketswil, Switzerland) integrated with
a treadmill (h/p/cosmos sports & medical GmbH,
Traunstein, Germany) and a motor-driven body weight
support system with real time feedback control for pre-
cise body weight unloading (Lokolift, Hocoma AG) to
apply RATE. A human-in-the-loop feedback system will
control each subject’s active work rate by projecting his
mechanical work rate onto a screen at the front of the
treadmill together with a target mechanical work rate.
Figure 2 illustrates the FC-RATE approach. The subject
will be instructed to vary the forces applied on the exo-
skeleton by volitional muscle activity and to keep the ac-
tual work rate as close as possible to the target. This
procedure will be used to assess the primary outcome
measures (aerobic capacity), and to guide each subject’s
individual target work rate during FC-RATE in the ex-
perimental group.
Pulmonary gas exchange and ventilatory measure-
ments will be carried out using breath-by-breath spiro-
metry (MetaMax 3B, Cortex Biophysik GmbH, Leipzig,
Germany). Prior to each test, a volume calibration will
be performed using a standardised volumetric syringe
and gas calibration will be carried out using ambient air
and a certified precision-analysed gas mixture. Heart
rate will be continuously measured and recorded by a
heart rate belt (T31, Polar Electro, Kempele, Finland)
and a receiver board (HRMI, Sparkfun, Boulder, USA).
Blood pressure will be monitored by a sphygmomanom-
eter (HEM- 907, Omron Corporation, Kyoto, Japan). A
software module for the overall procedure has been pro-
grammed in LabVIEW (Version 2009, National Instru-
ments, Austin TX, USA) [33].Joint forces/angles
. work rate calculation
solid line represents the mechanical work rate (Pmech) produced by
assive mechanical work rate (Ppassive) is evaluated before every session
moments of force, ωi = angular velocity, Ptotal = total mechanical
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The first RATE session will focus on adjusting the device
to provide a physiological gait pattern, and on familiar-
isation with the facemask for respiratory monitoring. An
initial test of decreasing body weight support (BWS)
continuously by 5% each minute will be carried out to
define individual BWS levels. Furthermore, we will im-
plement a short period of incremental exercise to fami-
liarise the subject with the feedback-control structure
and to estimate dynamic maximal voluntary contraction
during walking (MVC-W) within the exoskeleton to
adjust the individual target work rate for the following
exercise tests.
We will use constant load testing (CLT) [34] to imple-
ment a constant work load during RATE. Figure 3A
shows a schematic representation of the CLT protocol
that consists of: (1) a rest phase where subjects will
stand on the treadmill attached to the exoskeleton for 5
minutes with 0% BWS; (2) a passive phase where sub-
jects will walk passively with their individual BWS for 5
minutes; and (3) an active phase where subjects will be
instructed to actively contribute to the walking by push-
ing forward within the exoskeleton during the swing
phase of each leg to reach the target work rate, which
will be defined as 40% of MVC-W. The target work rate
profile will be displayed on a screen in front of the sub-
ject. Using real-time visual feedback of their actual work
rate the subjects will be asked to maintain their active
contribution as close as possible to the target work rate.


























Figure 3 Exercise testing protocols. Schematic representation of constan
controlled robotics-assisted treadmill exercise. The solid line represents the
line represents the target work rate (P*mech). The slope will be estimated su
When individual termination criteria are met the incremental phase is endepassive phase/recovery: subjects will be instructed to
walk passively with their individual BWS for 5 minutes;
(5) rest: subjects will stand on the treadmill, still at-
tached to the exoskeleton, for 5 minutes with 0% BWS.
Incremental exercise testing (IET) [35] will be used to
estimate peak cardiopulmonary performance parameters.
Figure 3B shows a schematic representation of the IET
protocol that consists of: (1) a passive phase where sub-
jects will be instructed to walk passively with their indi-
vidual BWS for 5 minutes; (2) and active phase where
subjects will be instructed to actively contribute to the
walking by pushing forward within the exoskeleton du-
ring the swing phase of each leg to reach peak exercise
capacity, where the slope will be defined so that MVC-
W is reached in approximately 10 minutes; and (3) a
passive phase/recovery where subjects will be instructed
to walk passively with their individual BWS for 5
minutes.
Both test protocols will follow strict termination cri-
teria for cardiopulmonary exercise testing including: (1)
abnormal blood pressure responses, that is, hypertensive
(systolic BP >210 mmHg or diastolic BP >115 mmHg)
when exercising at high work rate, or hypotensive re-
sponses (decrease in BP >10 mmHg) despite an increase
in work rate; (2) individual work rate below target work
rate for 60 s; (3) peak heart rate within 10 beats per mi-
nute of the age-predicted heart rate maximum [36],
where the formula will be adjusted down to 70% of heart
rate maximum for subjects on β-blocker medications










t load testing (A) and incremental exercise testing (B) using feedback-
mechanical work rate (Pmech) produced by the subject. The dashed
ch that the predefined peak work rate is reached after 10 minutes.
d and P*mech set back to the passive level.
Stoller et al. Trials 2013, 14:304 Page 7 of 10
http://www.trialsjournal.com/content/14/1/304follow established models for cardiopulmonary exercise
testing based on the ACSM guidelines [24].
The 10MWT and the 6MWT will be conducted using
standardised testing protocols in a quiet area. Standing
function will be assessed within parallel bars. The SIS
will be administered to the subjects on a face-to-face
basis.
Intervention
Both groups will receive regular RATE sessions (3/week,
30min/session) during their inpatient rehabilitation
period (typically, 4 to 12 weeks). Training intensity will
be recorded by continuous heart rate monitoring and
evaluating rate of perceived exertion (RPE) on the 6 to
20 scale [38]. The experimental group will receive pro-
gressive cardiovascular exercise using FC-RATE. Trai-
ning will start at 40% of peak work rate (based on initial
IET results) for the first session. Intensity will then be
adjusted by increasing the target work rate in 5% steps
for subsequent sessions based on heart rate and RPE
outcomes (target heart rate: 40 to 70% of heart rate re-
serve, target RPE: 11 to 14). The control group will re-
ceive conventional RATE, where therapists will focus on
gait quality only. To confirm or refute low cardiovascu-
lar training intensity in the control group (target heart
rate: ≤30% of heart rate reserve, target RPE: ≤7), thera-
pists will monitor heart rate and RPE during all training
sessions. All subjects will receive individually tailored
conventional therapy including physiotherapy (4 to 5
sessions/week, 30 to 60min/session), occupational the-
rapy (2 to 3 sessions/week, 30 to 60min/session), and
individual speech and language therapy.
Safety arrangements
There is an inherent risk during cardiopulmonary exer-
cise testing procedures and cardiovascular intervention
programmes for subjects with sub-acute stroke of a re-
current cerebral or cardiac event. Furthermore, subjects
are attached to the exoskeleton, which complicates
emergency procedures. Several risk management ar-
rangements will be implemented to ensure subjects’
safety: (1) clearly defined eligibility criteria to include
medically stable subjects only, (2) continuous blood
pressure monitoring during exercise testing (noted
above), (3) presence of resuscitation-trained assistants,
(4) opportunity to call the medical resuscitation team in
the clinic, and (5) presence of personnel trained to re-
lease the subject within 60 s from the exoskeleton.
Sample size and power calculation
The required sample size has been calculated based on
pooled estimation of standardised effect sizes obtained
from a previous meta-analysis on cardiovascular exercise
early after stroke [18]. Power analysis was done usingG*Power Software (Version 3.1, University of Dusseldorf,
Germany). A priori analysis indicated that a sample of at
least 14 subjects would provide a statistical power of
80%, that is, an 80% (β = 0.2) chance to detect a 20%
(α = 0.05) difference between groups. To allow for
dropouts, a total of 20 subjects will be recruited.
Data management and analysis
Data will be recorded on standardised forms and
concealed between examiners and therapists. All data
recorded continuously during testing will be saved auto-
matically by the software module and will only be ac-
cessible by an independent software specialist. Data set
examples will be checked for errors randomly or at any
time a serious adverse event occurs. Raw breath-by
-breath data will be processed using a zero phase shift
moving average filter over 15 breaths [39]. Peak cardio-
pulmonary response variables will be calculated by ana-
lysing the final 30 s during incremental exercise,
whereby criteria for maximal aerobic capacity will be (1)
plateau in oxygen uptake, (2) respiratory exchange ratio
(RER) ≥1.15, and (3) peak heart rate within 10 beats per
minute of the age-predicted heart rate maximum
(adjusted for subjects on β-blocker medications) [24].
Further peak performance variables will be defined as
the maximal values at the termination time of the IET.
The gas exchange threshold (GET) will be estimated
using the v-slope method and standard gas exchange cri-
teria [40]. Step response kinetics will be calculated using
a non-linear least-squares algorithm to fit the data as de-
scribed in the following mono-exponential equation:
VO2(t)=VO2(b)+ΔVO2(1-e
-(t-Td)/τ), t > 0, with VO2(b) =
oxygen uptake at baseline, ΔVO2 = step increase in oxy-
gen uptake, Td = time delay of 20 s corresponding to
the cardiodynamic phase of the response, and τ = time
constant [34]. Steady-state will be defined as the mean
value of the final 120 s during constant load phases. All
analyses will be performed using MATLAB (Version
R2010a, MathWorks, Natick MA, USA) and MetaSoft
(Version 3.9.6 SR1, Cortex Biophysik GmbH, Leipzig,
Germany).
Statistical analysis
Descriptive statistics will be calculated for dependent
and independent variables. Demographic and clinical
characteristics of the groups will be compared on admis-
sion using unpaired two-sample t-tests (continuous data)
and Chi-square analysis (categorical data). Nonparamet-
ric methods will be used when assumptions of normality
are violated. To evaluate the clinical efficacy of the
method, group differences will be compared after each
4-week intervention (t1, t2, t3, etcetera) using unpaired
two-sample t-tests for continuous data and z-tests for
categorical data that conform to the assumption of
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tinuous variables, Mann-Whitney U tests will be applied.
A mixed effects analysis of variance with repeated mea-
sures to model the intervention effects over time for
continuous variables that are normally distributed (that
is, aerobic capacity) will be applied. Non-parametric
tests (Mann-Whitney U and Kruskall Wallis tests) will
be used for categorical data (that is, SIS) or where a nor-
mal distribution is not present. Variables that are signifi-
cantly different in the baseline analysis will be used as
covariates for further analysis. Multiple regressions will
be applied to evaluate relationships among variables.
All statistical analysis will be performed using SPSS
(SPSS Inc., Chicago, Il, USA). The significance level
will be 0.05.
Discussion
The focus of this pilot trial is to evaluate the efficacy and
the feasibility of cardiovascular exercise using FC-RATE
with regard to aerobic capacity, motor recovery, and
quality-of-life early after stroke. Study results will con-
tribute to the evidence base regarding effects and feasi-
bility of a novel cardiovascular exercise intervention for
individuals suffering from severe motor impairment.
Furthermore, the results will help the development of
further methods for assessment of aerobic capacity
and guidance of exercise intensity during early stroke
rehabilitation.
It has previously been shown that cardiovascular exer-
cise is effective in improving aerobic capacity and walk-
ing distance in individuals with moderate or low
impairment after stroke [18]. However, there is a lack of
appropriate intervention methods to include highly im-
paired individuals with low motor status. Chang et al.
recently explored the effects of RATE on aerobic ca-
pacity and motor recovery early after stroke [41]. This
conventional approach of reducing BWS and guidance
torque, and increasing treadmill speed to guide exercise
intensity during RATE showed improved aerobic ca-
pacity and increased lower extremity strength in non-
ambulatory individuals. However, subjects received 2
weeks of regular exercise only, which is a relatively short
aerobic training volume, and the guidance of exercise
intensity using this conventional approach was reported
to be very difficult.
The present pilot trial will implement a feedback-
control structure for guidance of exercise intensity dur-
ing RATE. This is the first controlled clinical application
of this novel concept in an intervention study and might
be a first step into intensity-guided cardiovascular re-
habilitation research for individuals suffering from se-
vere motor impairment early after stroke. The long-term
objective of this research programme is to provide a basis
for exploration of the association of early cardiovascularactivation/exercise and neural plasticity. There are a few
studies that support this objective by reporting promi-
sing effects of early cardiovascular exercise on cognition
[42], motor function of the lower extremities [43,44],
and functional independence [45]. The present trial
could provide new insights into cardiovascular rehabili-
tation early after stroke and may, therefore, guide future
research on this topic. This will be relevant for further
development of rehabilitation robotics and future stroke
rehabilitation strategies.Conclusion
Our overall research plan aims to further develop and
implement robotics-assisted devices for cardiovascular
rehabilitation soon after stroke. The approach presented
here has been tested previously in a phase II clinical trial
that has shown feasibility of the concept for assessment
of aerobic capacity and guidance of cardiovascular exercise
in severely impaired individuals. The phase III clinical trial
described here aims to determine early indications of the
presence and magnitude of efficacy as well as to refine the
definition of the experimental protocol. If this trial is able
to show reasonable clinical feasibility and to demon-
strate having potential for efficacy on the primary out-
comes (aerobic capacity), further full-scale trials would
be warranted to investigate overall effectiveness of this
approach. In case of poor feasibility and low efficacy, the
concept might have to undergo further revision and de-
velopment to optimally support cardiovascular exercise
in severely impaired populations.Trial status
The trial was designed and commenced in 2012. The
expected time of completion of enrolment is June 2014.
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